Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Nicholas Williams, PhD, Joe Lee, MBBS, Luiza Moore, PhD, Joanna E Baxter, PhD, James Hewinson, PhD, Kevin J Dawson, PhD, Andrew Menzies, MSc, Anna L Godfrey, PhD, Anthony R Green, PhDFRCPath FMedSci, Peter J Campbell, PhD, Jyoti Nangalia, MBBChir

Blood (2020) 136 (Supplement_2): LBA-1.

https://doi.org/10.1182/blood-2020-143813

Published: 2020

Journal Articles

Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage

Ayala Tovy, PhD, Hyun Jung Park, PhD, Jaime M. Reyes, BS, Anna Guzman, Rachel E. Rau, MD, Aaron Jeffries, PhD, Mill Jonnathan, PhD, Emma Baple, PhD, Andrew Crosby, MD, Mia Petljak, Henry Lee-Six, PhD, Heng Wang, MD PhD, Xin Baozhong, MD PhD, Mathijs A. Sanders, PhD, Peter J. Campbell, PhD, Michael Stratton, Wei Li, Margaret Goodell, PhD

Blood (2018) 132 (Supplement 1): 173.

https://doi.org/10.1182/blood-2018-173

Published: 2018

Journal Articles

Whole Genome Sequencing Reveals Recurrent Structural Driver Events in Peripheral T-Cell Lymphomas Not Otherwise Specified

Francesco Maura, Niccolò Bolli, Daniel Leongamornlert, BS, Cristiana Carniti, Anna Dodero, MD, Federico Abascal, Adele Testi, Bernardo Rodriguez-Martin, Alessio Pellegrinelli, Giulia Biancon, Martina Magni, Annalisa Chiappella, MD, Inigo Martincorena, Jose M. C. Tubio, Giancarlo Pruneri, Peter J. Campbell, PhD, Paolo Corradini, MD

Blood (2018) 132 (Supplement 1): 4115.

https://doi.org/10.1182/blood-2018-99-112094

Published: 2018

Journal Articles

Modelling the Progression of a Preleukemic Stage to Overt Leukemia in Children with Down Syndrome

Blood (2018) 132 (Supplement 1): 543.

https://doi.org/10.1182/blood-2018-99-116661

Published: 2018

Journal Articles

The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis

Francesco Maura, Daniel Leongamornlert, BS, Nicos Angelopoulos, PhD, Kevin J Dawson, Mehmet Kemal Samur, PhD, Raphael Szalat, MD, Yu-Tzu Tai, PhD, Stephane Minvielle, PhD, Florence Magrangeas, Philippe Moreau, Paolo Corradini, MD, Kenneth C. Anderson, MD, Hervé Avet-Loiseau, MDPhD, Peter J. Campbell, PhD, Nikhil Munshi, MD, Niccolò Bolli

Blood (2018) 132 (Supplement 1): 109.

https://doi.org/10.1182/blood-2018-99-112420

Published: 2018

Journal Articles

Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients

Blood (2014) 124 (21): 4601.

https://doi.org/10.1182/blood.V124.21.4601.4601

Published: 2014

Journal Articles

A Next Generation Sequencing-Based Approach to Detect Gene Mutations, Copy Number Changes and IGH Translocations in Multiple Myeloma

Niccolo Bolli, MD PhD, Graham R Bignell, PhD, Peter Ganly, BMBCh, PhD, Elli Papaemmanuil, PhD, Herve Avet-Loiseau, Adam Sperling, MD PhD, Stephane Minvielle, Peter J Campbell, PhD, Nikhil C. Munshi, MD

Blood (2014) 124 (21): 3364.

https://doi.org/10.1182/blood.V124.21.3364.3364

Published: 2014

Journal Articles

TP53 Mutation Status Divides MDS Patients with Complex Karyotypes into Distinct Prognostic Risk Groups: Analysis of Combined Datasets from the International Working Group for MDS-Molecular Prognosis Committee

Blood (2014) 124 (21): 532.

https://doi.org/10.1182/blood.V124.21.532.532

Published: 2014

Journal Articles

Differential and Limited Expression of Mutant Alleles in Multiple Myeloma

Adam Sperling, MD PhD, Naim Rashid, PhD, Niccolo Bolli, MD PhD, David Wedge, PhD, Peter Van Loo, PhD, Yu-Tzu Tai, Masood Shammas, PhD, Mariateresa Fulciniti, PhD, Mehmet Kemal Samur, PhD, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, P Andrew Futreal, Kenneth C. Anderson, Herve Avet-loiseau, Peter J. Campbell, PhD, Giovanni Parmigiani, PhD, Nikhil Munshi

Blood (2014) 124 (21): 2007.

https://doi.org/10.1182/blood.V124.21.2007.2007

Published: 2014

Journal Articles

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2014) 124 (21): 825.

https://doi.org/10.1182/blood.V124.21.825.825

Published: 2014

Journal Articles

Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia

Blood (2014) 124 (21): 2212.

https://doi.org/10.1182/blood.V124.21.2212.2212

Published: 2014

Journal Articles

Aberration Of SF3B1 Results In Deregulated Splicing Of Key Genes and Pathways In Myelodysplastic Syndromes

Hamid Dolatshad, PhD, Marta Fernandez-Mercado, PhD, Bon Ham Yip, PhD, Chris J Smith, PhD, Martin Attwood, BSc, MRes, Cristina Di Genua, BSc, Natasha Sahgal, PhD, Bartlomiej P Przychodzen, PhD, Elli Papaemmanuil, PhD, Alexander A Kanapin, PhD, Helen Lockstone, PhD, Peter J. Campbell, PhD, Jaroslaw P. Maciejewski, MD, PhD, Andrea Pellagatti, PhD, Jacqueline Boultwood

Blood (2013) 122 (21): 2747.

https://doi.org/10.1182/blood.V122.21.2747.2747

Published: 2013

Journal Articles

Hierarchical Analysis Of Recurrent Point Mutations In SF3B1 and TET2 In RARS Stem Cells

Teresa Mortera-Blanco, PhD, Marios Dimitriou, PhD, Petter Woll, PhD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Simona Conte, Oni Chowdhuri, Monika Jansson, Peter J. Campbell, PhD, Sten Eirik W Jacobsen, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2013) 122 (21): 2749.

https://doi.org/10.1182/blood.V122.21.2749.2749

Published: 2013

Journal Articles

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Ilaria Ambaglio, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Chiara Elena, MD, Marta Ubezio, MD, Elisa Bono, MD, Matteo C Da Vià, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 2755.

https://doi.org/10.1182/blood.V122.21.2755.2755

Published: 2013

Journal Articles

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Chiara Elena, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Ilaria Ambaglio, MD, Marta Ubezio, MD, Matteo C Da Vià, MD, Elisa Bono, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1532.

https://doi.org/10.1182/blood.V122.21.1532.1532

Published: 2013

Journal Articles

Order Matters: Sequence Of Mutation Acquisition In Myeloproliferative Neoplasms Impacts Disease Pathogenesis and Stem Cell Potency

David G. Kent, PhD, Christina Ortmann, MD, Yvonne Silber, Joanna Baxter, PhD, Beatriz Bellosillo, Konstanze Doehner, MD, Peter J. Campbell, PhD, Anthony R Green

Blood (2013) 122 (21): 2888.

https://doi.org/10.1182/blood.V122.21.2888.2888

Published: 2013

Journal Articles

The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients

Jyoti Nangalia, MBBChir FRCPath, Charles Massie, PhD, E Joanna Baxter, PhD, Francesca L Nice, MRes, Gunes Gundem, PhD, David Wedge, PhD, Edward Avezov, PhD, Juan Li, PhD, Karoline Kollmann, PhD, David G. Kent, PhD, Athar Aziz, PhD, Anna L Godfrey, BMBCh FRCPath, Jonathan Hinton, MSc, Inigo Martincorena, PhD, Peter Van Loo, PhD, Amy V Jones, PhD, Paola Guglielmelli, PhD MD, Patrick Tarpey, PhD, Heather P Harding, PhD, John D Fitzpatrick, BA, Calum T Goudie, BA, Christina A Ortmann, MD, Stephen J Loughran, PhD, Keiran Raine, MSc, David Jones, MSc, Adam Butler, MSc, Jon W Teague, MSc, Sarah O'Meara, Stuart McLaren, Michele Bianchi, Yvonne Silber, MSc, Danai Dimitropolou, BSc, David Bloxham, MSc FRCPath, Laura J Mudie, BSc, Mark Maddison, BSc, Ben Robinson, BSc, Clodagh Keohane, MD, Cathy MacLean, MSc, Kate Hill, BM BS, Kim H. Orchard, MBBS, PhD, FRCP, FRCPath, Sudhir Tauro, PhD, Ming-Qing Du, MB, PhD, Mel Greaves, PhD, FRS, David Bowen, MD, PhD, Brian Huntly, MBChB FRCPath PhD, Claire N Harrison, DM, FRCP, FRCPath, Nicholas C.P. Cross, PhD, FRCPath, David Ron, MD, Alessandro M Vannucchi, MD, Elli Papaemmanuil, PhD, Peter J. Campbell, PhD, Anthony R Green, FRCPath FMedSci

Blood (2013) 122 (21): LBA-2.

https://doi.org/10.1182/blood.V122.21.LBA-2.LBA-2

Published: 2013

Journal Articles

Genomic Evolution and Clinical Correlates

Peter J. Campbell, PhD

Blood (2013) 122 (21): SCI-15.

https://doi.org/10.1182/blood.V122.21.SCI-15.SCI-15

Published: 2013

Journal Articles

Association Between Gene Expression Profiles and Commonly Mutated Genes In The Hematopoietic Stem Cells Of Patients With Myelodysplastic Syndromes

Andrea Pellagatti, PhD, Moritz Gerstung, PhD, Elli Papaemmanuil, PhD, Luca Malcovati, MD, Aristoteles Giagounidis, MD, PhD, Matteo G Della Porta, MD, Martin Jadersten, MD, PhD, Amit Verma, MD, Paresh Vyas, MD, PhD, Sally Killick, MD, Eva Hellstrom-Lindberg, MD, Mario Cazzola, MD, Peter J. Campbell, PhD, Jacqueline Boultwood

Blood (2013) 122 (21): 2779.

https://doi.org/10.1182/blood.V122.21.2779.2779

Published: 2013

Journal Articles

Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation

Simona Conte, Liselotte Vesterlund, PhD, Shintaro Katayama, PhD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Monika Jansson, Teresa Mortera-Blanco, PhD, Marios Dimitriou, PhD, Birgitta Sander, MD, PhD, Tiina Skoog, Peter J. Campbell, PhD, Juha Kere, MD, PhD, Per Unneberg, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2013) 122 (21): 2408.

https://doi.org/10.1182/blood.V122.21.2408.2408

Published: 2013

NARROW

Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms

Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage

Whole Genome Sequencing Reveals Recurrent Structural Driver Events in Peripheral T-Cell Lymphomas Not Otherwise Specified

Modelling the Progression of a Preleukemic Stage to Overt Leukemia in Children with Down Syndrome

The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis

Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients

A Next Generation Sequencing-Based Approach to Detect Gene Mutations, Copy Number Changes and IGH Translocations in Multiple Myeloma

TP53 Mutation Status Divides MDS Patients with Complex Karyotypes into Distinct Prognostic Risk Groups: Analysis of Combined Datasets from the International Working Group for MDS-Molecular Prognosis Committee

Differential and Limited Expression of Mutant Alleles in Multiple Myeloma

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia

Aberration Of SF3B1 Results In Deregulated Splicing Of Key Genes and Pathways In Myelodysplastic Syndromes

Hierarchical Analysis Of Recurrent Point Mutations In SF3B1 and TET2 In RARS Stem Cells

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Order Matters: Sequence Of Mutation Acquisition In Myeloproliferative Neoplasms Impacts Disease Pathogenesis and Stem Cell Potency

The Genomic Landscape of Myeloproliferative Neoplasms: Somatic Calr Mutations in the Majority of JAK2-Wildtype Patients

Genomic Evolution and Clinical Correlates

Association Between Gene Expression Profiles and Commonly Mutated Genes In The Hematopoietic Stem Cells Of Patients With Myelodysplastic Syndromes

Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only